# US 2013/0156851 A1 · Lipomacrocycles and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156851 A1
- Document ID: US20130156851A1
- Status: Published application
- Kind: A1
- Application number: 13/819,147
- Filed: 2011-08-26
- Published: 2013-06-20
- Earliest claimed: 2010-08-26
- Inventors: Kunyuan Cui; Dong Liang
- Web page: https://patentgrep.com/patent/US20130156851A1

## CPC

- C07D 487/22: in which the condensed system contains four or more hetero rings
- A61K 47/544: {Phospholipids}
- A61K 47/549: {Sugars, nucleosides, nucleotides or nucleic acids}
- A61K 47/55: the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 255/02: not condensed with other rings
- C07D 257/02: not condensed with other rings
- C07D 259/00: Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
- C07D 295/13: to an acyclic saturated chain
- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

What is described are macrocyclic compounds formed by reaction of a cyclic compound, which contains an amine, with an epoxide. The macrocyclic compound has the following structure: When substituents R and R′ that are hydrophobic substituents, the macrocyclic compound functions as a lipid and is compatible with lipid systems, including liposomes and lipid particles. When present in certain lipid systems, the macrocyclic compound enhances the ability of the lipid system to facilitate delivery of therapeutic molecules to target cells in a mammalian subject.

## Claims

### Claim 1

A macrocyclic compound produced by reacting a cyclic compound consisting of formula I
with an epoxide consisting of formula II or III
wherein X is N, O or S, wherein X may vary in the cyclic compound; wherein when X is O or S, then R is nothing, and when X is N, then R is selected from a group consisting of H, a linear or branched alkyl, an aryl, a cholesterol, CH2CONH2, CH2CONHCH3, a methylene bridge between a pair of the amino groups of the cyclic compound, or an ethylene bridge between pairs of amino groups of the cyclic compound; wherein more than one R group may occur in the cyclic compound; wherein the CH2—XR—CH2 group of the cyclic compound repeats from m=2 to 10 times, wherein for every repeat of the CH2—XR—CH2 group, n is 0 or 1; and wherein R′ is C1 to C20.

### Claim 2 (depends on 1)

The macrocyclic compound of claim 1, comprising at least one amine.

### Claim 3 (depends on 2)

The macrocyclic compound of claim 2, wherein the cyclic compound is selected from the group consisting of:

### Claim 4 (depends on 2)

The macrocyclic compound of claim 2, wherein the macrocyclic compound in an aqueous solution at neutral pH has molecular structure of formula IV:

### Claim 5 (depends on 4)

The macrocyclic compound of claim 4, comprising a quaternary ammonium or a tertiary amine or both.

### Claim 6 (depends on 1)

The macrocyclic compound of claim 1, wherein the cyclic compound is reacted with an amount of epoxide that is proportional to the number of amines in the cyclic compound.

### Claim 7 (depends on 1)

The macrocyclic compound of claim 1, wherein the cyclic compound is reacted with an amount of epoxide that is less than the number of amines in the cyclic compound.

### Claim 8 (depends on 1)

The macrocyclic compound of claim 1, wherein the cyclic compound is reacted with an amount of epoxide that is proportional to the amount of the cyclic compound.

### Claim 9 (depends on 4)

The macrocyclic compound of claim 4, wherein R′ consists an molecular substituent selected from the group consisting of CH2—O—(CH2)9CH3, CH2—O—(CH2)11CH3, CH2—O—(CH2)13CH3, (CH2)9CH3, (CH2)11CH3, (CH2)11CH3, (CH2)13CH3, (CH2)15CH3 and CH2—O—CH(CH2CH3)((CH2)11CH3).

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The macrocyclic compound according to any of claim 1, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 16 (depends on 14)

The macrocyclic compound according to any of claim 14, wherein the polynucleotide is an RNA molecule.

### Claim 17 (depends on 16)

The macrocyclic compound of claim 16, wherein the RNA molecule is an siRNA molecule.

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The macrocyclic compound according to any of claim 1, wherein the macrocyclic compound is a component of a liposome or a lipid particle.

### Claim 20

(canceled)

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24 (depends on 2)

The macrocyclic compound according to any of claim 2, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 25 (depends on 3)

The macrocyclic compound according to any of claim 3, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 26 (depends on 4)

The macrocyclic compound according to any of claim 4, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 27 (depends on 5)

The macrocyclic compound according to any of claim 5, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 28 (depends on 6)

The macrocyclic compound according to any of claim 6, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 29 (depends on 7)

The macrocyclic compound according to any of claim 7, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 30 (depends on 8)

The macrocyclic compound according to any of claim 8, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 31 (depends on 9)

The macrocyclic compound according to any of claim 9, wherein the macrocyclic compound is in a lipid-polynucleotide particle comprising a lipid and a polynucleotide.

### Claim 32 (depends on 24)

The macrocyclic compound according to any of claim 24, wherein the polynucleotide is an RNA molecule.

### Claim 33 (depends on 25)

The macrocyclic compound according to any of claim 25, wherein the polynucleotide is an RNA molecule.

### Claim 34 (depends on 26)

The macrocyclic compound according to any of claim 26, wherein the polynucleotide is an RNA molecule.

### Claim 35 (depends on 27)

The macrocyclic compound according to any of claim 27, wherein the polynucleotide is an RNA molecule.

### Claim 36 (depends on 28)

The macrocyclic compound according to any of claim 28, wherein the polynucleotide is an RNA molecule.

### Claim 37 (depends on 29)

The macrocyclic compound according to any of claim 29, wherein the polynucleotide is an RNA molecule.

### Claim 38 (depends on 30)

The macrocyclic compound according to any of claim 30, wherein the polynucleotide is an RNA molecule.

### Claim 39 (depends on 31)

The macrocyclic compound according to any of claim 31, wherein the polynucleotide is an RNA molecule.

### Claim 40 (depends on 32)

The macrocyclic compound of claim 32, wherein the RNA molecule is an siRNA molecule.

### Claim 41 (depends on 33)

The macrocyclic compound of claim 33, wherein the RNA molecule is an siRNA molecule.

### Claim 42 (depends on 34)

The macrocyclic compound of claim 34, wherein the RNA molecule is an siRNA molecule.

### Claim 43 (depends on 35)

The macrocyclic compound of claim 35, wherein the RNA molecule is an siRNA molecule.

### Claim 44 (depends on 36)

The macrocyclic compound of claim 36, wherein the RNA molecule is an siRNA molecule.

### Claim 45 (depends on 37)

The macrocyclic compound of claim 37, wherein the RNA molecule is an siRNA molecule.

### Claim 46 (depends on 38)

The macrocyclic compound of claim 38, wherein the RNA molecule is an siRNA molecule.

### Claim 47 (depends on 39)

The macrocyclic compound of claim 39, wherein the RNA molecule is an siRNA molecule.

### Claim 48 (depends on 2)

The macrocyclic compound according to any of claim 2, wherein the macrocyclic compound is a component of a liposome or a lipid particle.

### Claim 49 (depends on 3)

The macrocyclic compound according to any of claim 3, wherein the macrocyclic compound is a component of a liposome or a lipid particle.

### Claim 50 (depends on 4)

The macrocyclic compound according to any of claim 4, wherein the macrocyclic compound is a component of a liposome or a lipid particle.

### Claim 51 (depends on 5)

The macrocyclic compound according to any of claim 5, wherein the macrocyclic compound is a component of a liposome or a lipid particle.

### Claim 52 (depends on 6)

The macrocyclic compound according to any of claim 6, wherein the macrocyclic compound is a component of a liposome or a lipid particle.

### Claim 53 (depends on 7)

The macrocyclic compound according to any of claim 7, wherein the macrocyclic compound is a component of a liposome or a lipid particle.

### Claim 54 (depends on 8)

The macrocyclic compound according to any of claim 8, wherein the macrocyclic compound is a component of a liposome or a lipid particle.

### Claim 55 (depends on 9)

The macrocyclic compound according to any of claim 9, wherein the macrocyclic compound is a component of a liposome or a lipid particle.
